Invitation strategies and coverage in the population-based cancer screening programmes in the European Union

The aim of this study was to describe the compliance of the population-based cancer screening programmes in the European Union Member States to the invitation strategies enumerated in the European Guidelines and the impact of such strategies on the invitational coverage. Experts in screening programme monitoring from the respective countries provided data. Coverage by invitation was calculated as the proportion of individuals in the target age range receiving a screening invitation over the total number of annualized eligible population. The invitation strategies of 30 breasts, 25 cervical and 27 colorectal national or regional population-based screening programmes are described. Individual mail invitations are sent by 28 breasts, 20 cervical and 25 colorectal screening programmes. Faecal occult blood test kits are sent by post in 17 of the colorectal cancer screening programmes. The majority of programmes claimed to have a population registry, although some use health insurance data as the database for sending invitations. At least 95% invitation coverage was reached by 16 breast, six cervical and five colorectal screening programmes. Majority of the programmes comply with the invitation strategies enumerated in the European guidelines, although there is still scope for improvements. Coverage by invitation is below the desirable level in many population-based cancer screening programmes in European Union.

[1]  I. Soerjomataram,et al.  Status of implementation and organization of cancer screening in The European Union Member States—Summary results from the second European screening report , 2018, International journal of cancer.

[2]  M. Blettner,et al.  Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study , 2016, International journal of cancer.

[3]  Jennifer S Lin,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2016, JAMA.

[4]  I. Jatoi.  Breast-Cancer Screening--Viewpoint of the IARC Working Group. , 2015, The New England journal of medicine.

[5]  K. Straif,et al.  Breast-cancer screening--viewpoint of the IARC Working Group. , 2015, The New England journal of medicine.

[6]  M. Federico,et al.  Changes in cervical cancer incidence following the introduction of organized screening in Italy. , 2015, Preventive medicine.

[7]  Joakim Dillner,et al.  Cervical cancer screening in Europe: Quality assurance and organisation of programmes. , 2015, European journal of cancer.

[8]  K. Canfell,et al.  The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England , 2013, Cancer Causes & Control.

[9]  P. Giorgi Rossi,et al.  How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access. , 2012, Preventive medicine.

[10]  C. de Wolf,et al.  Mammographic Screening Programmes in Europe: Organization, Coverage and Participation , 2012, Journal of medical screening.

[11]  B. Walsh,et al.  The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15. , 2011, Health policy.

[12]  L. Palència,et al.  Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. , 2010, International journal of epidemiology.

[13]  G. Ronco,et al.  Cervical cancer screening policies and coverage in Europe. , 2009, European journal of cancer.

[14]  M. Hakama,et al.  Implementation of Colorectal Cancer Screening in Finland: Experiences from the First Three Years of a Public Health Programme , 2008, Zeitschrift fur Gastroenterologie.

[15]  Consumer Protection,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Jacques Ferlay,et al.  Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. , 2008 .

[17]  A. Herbert,et al.  European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.

[18]  Elizabeth Cox,et al.  Efficacy of patient letter reminders on cervical cancer screening , 2001, Journal of General Internal Medicine.

[19]  P. Giorgi Rossi,et al.  The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial , 2005, Journal of medical screening.

[20]  H. Adami,et al.  A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  S. Cole,et al.  Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner , 2002, Journal of medical screening.

[22]  J. Nygård,et al.  The cervical cancer screening programme in Norway, 1992–2000: changes in Pap smear coverage and incidence of cervical cancer , 2002, Journal of medical screening.

[23]  C. Forbes,et al.  Interventions targeted at women to encourage the uptake of cervical screening. , 2021, The Cochrane database of systematic reviews.

[24]  P. Edwards,et al.  British Medical Journal , 1876 .

[25]  A. Ponti,et al.  Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. , 1997, European journal of cancer.

[26]  S. Ciatto,et al.  Cancer screening in the European Union. , 1994, European journal of cancer.

[27]  A. Ponti,et al.  Practice of Early Diagnosis of Breast and Uterine Cervix Cancer in a Northern Italian Town , 1990, Tumori.

[28]  N. Day,et al.  Breast cancer screening programmes: the development of a monitoring and evaluation system. , 1989, British Journal of Cancer.

[29]  N. Day,et al.  TRENDS IN MORTALITY FROM CERVICAL CANCER IN THE NORDIC COUNTRIES: ASSOCIATION WITH ORGANISED SCREENING PROGRAMMES , 1987, The Lancet.

[30]  J. Dankert,et al.  PHAGOCYTOSIS IN CHRONIC GRANULOMATOUS DISEASE , 1975, The Lancet.